首页 > 最新文献

Chinese Herbal Medicines最新文献

英文 中文
Hypoxia inducible factor-1α related mechanism and TCM intervention in process of early fracture healing 缺氧诱导因子-1α在骨折早期愈合过程中的相关机制与中医干预
IF 3.8 4区 医学 Q2 Medicine Pub Date : 2024-01-01 DOI: 10.1016/j.chmed.2023.09.006
Wenxian Zhang , Fusen Yang , Qikai Yan , Jiahui Li , Xiaogang Zhang , Yiwei Jiang , Jianye Dai

As a common clinical disease, fracture is often accompanied by pain, swelling, bleeding as well as other symptoms and has a high disability rate, even threatening life, seriously endangering patients’ physical and psychological health and quality of life. Medical practitioners take many strategies for the treatment of fracture healing, including Traditional Chinese Medicine (TCM). In the early stage of fracture healing, the local fracture is often in a state of hypoxia, accompanied by the expression of hypoxia inducible factor-1α (HIF-1α), which is beneficial to wound healing. Through literature mining, we thought that hypoxia, HIF-1α and downstream factors affected the mechanism of fracture healing, as well as dominated this process. Therefore, we reviewed the local characteristics and related signaling pathways involved in the fracture healing process and summarized the intervention of TCM on these mechanisms, in order to inspirit the new strategy for fracture healing, as well as elaborate on the possible principles of TCM in treating fractures based on the HIF molecular mechanism.

骨折是临床常见疾病,常伴有疼痛、肿胀、出血等症状,致残率高,甚至危及生命,严重危害患者的身心健康和生活质量。对于骨折愈合的治疗,医学家们采取了多种策略,其中包括中医疗法。在骨折愈合早期,骨折局部往往处于缺氧状态,同时伴有有利于伤口愈合的缺氧诱导因子-1α(HIF-1α)的表达。通过文献挖掘,我们认为缺氧、HIF-1α及下游因子影响骨折愈合的机制,并主导这一过程。因此,我们回顾了骨折愈合过程中的局部特征和相关信号通路,总结了中医药对这些机制的干预,以启发骨折愈合的新策略,并阐述了基于HIF分子机制的中医药治疗骨折的可能原则。
{"title":"Hypoxia inducible factor-1α related mechanism and TCM intervention in process of early fracture healing","authors":"Wenxian Zhang ,&nbsp;Fusen Yang ,&nbsp;Qikai Yan ,&nbsp;Jiahui Li ,&nbsp;Xiaogang Zhang ,&nbsp;Yiwei Jiang ,&nbsp;Jianye Dai","doi":"10.1016/j.chmed.2023.09.006","DOIUrl":"https://doi.org/10.1016/j.chmed.2023.09.006","url":null,"abstract":"<div><p>As a common clinical disease, fracture is often accompanied by pain, swelling, bleeding as well as other symptoms and has a high disability rate, even threatening life, seriously endangering patients’ physical and psychological health and quality of life. Medical practitioners take many strategies for the treatment of fracture healing, including Traditional Chinese Medicine (TCM). In the early stage of fracture healing, the local fracture is often in a state of hypoxia, accompanied by the expression of hypoxia inducible factor-1α (HIF-1α), which is beneficial to wound healing. Through literature mining, we thought that hypoxia, HIF-1α and downstream factors affected the mechanism of fracture healing, as well as dominated this process. Therefore, we reviewed the local characteristics and related signaling pathways involved in the fracture healing process and summarized the intervention of TCM on these mechanisms, in order to inspirit the new strategy for fracture healing, as well as elaborate on the possible principles of TCM in treating fractures based on the HIF molecular mechanism.</p></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1674638423001090/pdfft?md5=a96bbfc2243d898f365d9f56fad6f10f&pid=1-s2.0-S1674638423001090-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139714504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Xiaoyao San on exercise capacity and liver mitochondrial metabolomics in rat depression model 小枣散对抑郁模型大鼠运动能力和肝线粒体代谢组学的影响
IF 3.8 4区 医学 Q2 Medicine Pub Date : 2024-01-01 DOI: 10.1016/j.chmed.2023.09.004
Weidi Zhao , Cui Ji , Jie Zheng , Shi Zhou , Junsheng Tian , Yumei Han , Xuemei Qin

Objective

This study aimed to investigate the therapeutic effects of Xiaoyao San (XYS), a herbal medicine formula, on exercise capacity and liver mitochondrial metabolomics in a rat model of depression induced by chronic unpredictable mild stress (CUMS).

Methods

A total of 24 male SD rats were randomly divided into four groups: control group (C), CUMS control group (M), Venlafaxine positive treatment group (V), and XYS treatment group (X). Depressive behaviour and exercise capacity of rats were assessed by body weight, sugar-water preference test, open field test, pole test, and rotarod test. The liver mitochondria metabolomics were analyzed by using liquid chromatography-mass spectrometry (LC-MS) method. TCMSP database and GeneCards database were used to screen XYS for potential targets for depression, and GO and KEGG enrichment analyses were performed.

Results

Compared with C group, rats in M group showed significantly lower body weight, sugar water preference rate, number of crossing and rearing in the open field test, climbing down time in the pole test, and retention time on the rotarod test (P < 0.01). The above behaviors and exercise capacity indices were significantly modulated in rats in V and X groups compared with M group (P < 0.05, 0.01). Compared with C group, a total of 18 different metabolites were changed in the liver mitochondria of rats in M group. Nine different metabolites and six metabolic pathways were regulated in the liver mitochondria of rats in X group compared with M group. The results of network pharmacology showed that 88 intersecting targets for depression and XYS were obtained, among which 15 key targets such as IL-1β, IL-6, and TNF were predicted to be the main differential targets for the treatment of depression. Additionally, a total of 1 553 GO signaling pathways and 181 KEGG signaling pathways were identified, and the main biological pathways were AGE-RAGE signaling pathway, HIF-1 signaling pathway, and calcium signaling pathway.

Conclusion

XYS treatment could improve depressive symptoms, enhance exercise capacity, positively regulate the changes of mitochondrial metabolites and improve energy metabolism in the liver of depressed rats. These findings suggest that XYS exerts antidepressant effects through multi-target and multi-pathway.

方法将24只雄性SD大鼠随机分为4组:对照组(C)、CUMS对照组(M)、文拉法辛阳性治疗组(V)和XYS治疗组(X)。大鼠的抑郁行为和运动能力通过体重、糖水偏好试验、开阔地试验、撑竿试验和转体试验进行评估。采用液相色谱-质谱(LC-MS)方法对肝脏线粒体代谢组学进行分析。结果与C组相比,M组大鼠的体重、糖水偏好率、空地试验中的穿越次数和饲养次数、杆式试验中的爬下时间和转体试验中的停留时间均显著降低(P <0.01)。与 M 组相比,V 组和 X 组大鼠的上述行为和运动能力指数都有明显的改变(P < 0.05, 0.01)。与 C 组相比,M 组大鼠肝脏线粒体中总共有 18 种不同的代谢物发生了变化。与 M 组相比,X 组大鼠肝脏线粒体中有 9 种不同的代谢物和 6 条代谢途径受到调控。网络药理学结果显示,抑郁症与XYS有88个交叉靶点,其中IL-1β、IL-6和TNF等15个关键靶点被预测为治疗抑郁症的主要差异靶点。结论 XYS治疗可改善抑郁症状,提高运动能力,正向调节线粒体代谢产物的变化,改善抑郁大鼠肝脏的能量代谢。这些研究结果表明,XYS通过多靶点、多途径发挥抗抑郁作用。
{"title":"Effects of Xiaoyao San on exercise capacity and liver mitochondrial metabolomics in rat depression model","authors":"Weidi Zhao ,&nbsp;Cui Ji ,&nbsp;Jie Zheng ,&nbsp;Shi Zhou ,&nbsp;Junsheng Tian ,&nbsp;Yumei Han ,&nbsp;Xuemei Qin","doi":"10.1016/j.chmed.2023.09.004","DOIUrl":"10.1016/j.chmed.2023.09.004","url":null,"abstract":"<div><h3>Objective</h3><p>This study aimed to investigate the therapeutic effects of Xiaoyao San (XYS), a herbal medicine formula, on exercise capacity and liver mitochondrial metabolomics in a rat model of depression induced by chronic unpredictable mild stress (CUMS).</p></div><div><h3>Methods</h3><p>A total of 24 male SD rats were randomly divided into four groups: control group (C), CUMS control group (M), Venlafaxine positive treatment group (V), and XYS treatment group (X). Depressive behaviour and exercise capacity of rats were assessed by body weight, sugar-water preference test, open field test, pole test, and rotarod test. The liver mitochondria metabolomics were analyzed by using liquid chromatography-mass spectrometry (LC-MS) method. TCMSP database and GeneCards database were used to screen XYS for potential targets for depression, and GO and KEGG enrichment analyses were performed.</p></div><div><h3>Results</h3><p>Compared with C group, rats in M group showed significantly lower body weight, sugar water preference rate, number of crossing and rearing in the open field test, climbing down time in the pole test, and retention time on the rotarod test (<em>P</em> &lt; 0.01). The above behaviors and exercise capacity indices were significantly modulated in rats in V and X groups compared with M group (<em>P</em> &lt; 0.05, 0.01). Compared with C group, a total of 18 different metabolites were changed in the liver mitochondria of rats in M group. Nine different metabolites and six metabolic pathways were regulated in the liver mitochondria of rats in X group compared with M group. The results of network pharmacology showed that 88 intersecting targets for depression and XYS were obtained, among which 15 key targets such as IL-1β, IL-6, and TNF were predicted to be the main differential targets for the treatment of depression. Additionally, a total of 1 553 GO signaling pathways and 181 KEGG signaling pathways were identified, and the main biological pathways were AGE-RAGE signaling pathway, HIF-1 signaling pathway, and calcium signaling pathway.</p></div><div><h3>Conclusion</h3><p>XYS treatment could improve depressive symptoms, enhance exercise capacity, positively regulate the changes of mitochondrial metabolites and improve energy metabolism in the liver of depressed rats. These findings suggest that XYS exerts antidepressant effects through multi-target and multi-pathway.</p></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1674638423001053/pdfft?md5=25e4dd637e588532f906c703ab9c5f4f&pid=1-s2.0-S1674638423001053-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138609706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Potential efficacy and mechanism of eight mild-natured and bitter-flavored TCMs based on gut microbiota: A review 基于肠道微生物群的八种性味平和、味苦的中药的潜在疗效和作用机制综述
IF 3.8 4区 医学 Q2 Medicine Pub Date : 2024-01-01 DOI: 10.1016/j.chmed.2023.08.001
Wenquan Su , Yanan Yang , Xiaohui Zhao , Jiale Cheng , Yuan Li , Shengxian Wu , Chongming Wu

The mild-natured and bitter-flavored traditional Chinese medicines (MB-TCMs) are an important class of TCMs that have been widely used in clinical practice and recognized as safe long-term treatments for chronic diseases. However, as an important class of TCMs, the panorama of pharmacological effects and the mechanisms of MB-TCMs have not been systemically reviewed. Compelling studies have shown that gut microbiota can mediate the therapeutic activity of TCMs and help to elucidate the core principles of TCM medicinal theory. In this systematic review, we found that MB-TCMs commonly participated in the modulation of metabolic syndrome, intestinal inflammation, nervous system disease and cardiovascular system disease in association with promoting the growth of beneficial bacteria Bacteroides, Akkermansia, Lactobacillus, Bifidobacterium, Roseburia as well as inhibiting the proliferation of harmful bacteria Helicobacter, Enterococcus, Desulfovibrio and Escherichia-Shigella. These alterations, correspondingly, enhance the generation of protective metabolites, mainly including short-chain fatty acids (SCFAs), bile acid (BAs), 5-hydroxytryptamine (5-HT), indole and gamma-aminobutyric acid (GABA), and inhibit the generation of harmful metabolites, such as proinflammatory factors trimethylamine oxide (TAMO) and lipopolysaccharide (LPS), to further exert multiplicative effects for the maintenance of human health through several different signaling pathways. Altogether, this present review has attempted to comprehensively summarize the relationship between MB-TCMs and gut microbiota by establishing the TCMs-gut microbiota-metabolite-signaling pathway-diseases axis, which may provide new insight into the study of TCM medicinal theories and their clinical applications.

性味平和、味苦的中药(MB-TCMs)是一类重要的中药,已被广泛应用于临床,并被公认为慢性疾病的长期安全疗法。然而,作为一类重要的中药,中药的药理作用及其机制尚未得到系统的研究。令人信服的研究表明,肠道微生物群可介导中药的治疗活性,并有助于阐明中医药理论的核心原理。在本系统综述中,我们发现甲基溴中药通常参与调节代谢综合征、肠道炎症、神经系统疾病和心血管系统疾病,与促进有益菌 Bacteroides、Akkermansia、Lactobacillus、Bifidobacterium、Roseburia 的生长以及抑制有害菌 Helicobacter、Enterococcus、Desulfovibrio 和 Escherichia-Shigella 的增殖有关。这些变化相应地促进了保护性代谢物的生成,主要包括短链脂肪酸(SCFA)、胆汁酸(BA)、5-羟色胺(5-HT)、吲哚和γ-氨基丁酸(GABA),并抑制了有害代谢物的生成,如促炎性因子氧化三甲胺(TAMO)和脂多糖(LPS),从而通过几种不同的信号通路进一步发挥了维护人体健康的多重效应。总之,本综述试图通过建立中药-肠道微生物群-代谢产物-信号通路-疾病轴,全面总结甲基溴-中药与肠道微生物群之间的关系,从而为中药药理研究及其临床应用提供新的见解。
{"title":"Potential efficacy and mechanism of eight mild-natured and bitter-flavored TCMs based on gut microbiota: A review","authors":"Wenquan Su ,&nbsp;Yanan Yang ,&nbsp;Xiaohui Zhao ,&nbsp;Jiale Cheng ,&nbsp;Yuan Li ,&nbsp;Shengxian Wu ,&nbsp;Chongming Wu","doi":"10.1016/j.chmed.2023.08.001","DOIUrl":"10.1016/j.chmed.2023.08.001","url":null,"abstract":"<div><p>The mild-natured and bitter-flavored traditional Chinese medicines (MB-TCMs) are an important class of TCMs that have been widely used in clinical practice and recognized as safe long-term treatments for chronic diseases. However, as an important class of TCMs, the panorama of pharmacological effects and the mechanisms of MB-TCMs have not been systemically reviewed. Compelling studies have shown that gut microbiota can mediate the therapeutic activity of TCMs and help to elucidate the core principles of TCM medicinal theory. In this systematic review, we found that MB-TCMs commonly participated in the modulation of metabolic syndrome, intestinal inflammation, nervous system disease and cardiovascular system disease in association with promoting the growth of beneficial bacteria <em>Bacteroides</em>, <em>Akkermansia</em>, <em>Lactobacillus</em>, <em>Bifidobacterium</em>, <em>Roseburia</em> as well as inhibiting the proliferation of harmful bacteria <em>Helicobacter</em>, <em>Enterococcus</em>, <em>Desulfovibrio</em> and <em>Escherichia-Shigella</em>. These alterations, correspondingly, enhance the generation of protective metabolites, mainly including short-chain fatty acids (SCFAs), bile acid (BAs), 5-hydroxytryptamine (5-HT), indole and gamma-aminobutyric acid (GABA), and inhibit the generation of harmful metabolites, such as proinflammatory factors trimethylamine oxide (TAMO) and lipopolysaccharide (LPS), to further exert multiplicative effects for the maintenance of human health through several different signaling pathways. Altogether, this present review has attempted to comprehensively summarize the relationship between MB-TCMs and gut microbiota by establishing the TCMs-gut microbiota-metabolite-signaling pathway-diseases axis, which may provide new insight into the study of TCM medicinal theories and their clinical applications.</p></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1674638423001077/pdfft?md5=086c0458eea82486fd36d89f25b2ec44&pid=1-s2.0-S1674638423001077-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139016776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chemical composition and pharmacological activity of seco-prezizaane-type sesquiterpenes seco-prezizaane-类型倍半萜的化学成分和药理活性
IF 3.8 4区 医学 Q2 Medicine Pub Date : 2024-01-01 DOI: 10.1016/j.chmed.2023.06.003
Ye Jin , Yanqing Xie , Peng Zhang , Afsar Khan , Zhihong Zhou , Lu Liu

The seco-prezizaane-type sesquiterpenes (SPS), as a special class of sesquiterpenes with a highly oxidative five-ring cage structure and seven consecutive chiral centers, are isolated from the genus Illicium, which have a variety of biological activities, including neurotoxicity and neurotrophic effects, etc. This review summarizes the chemical constituents and pharmacological effects of SPS, and discusses the potential trend and scope of future research.

seco-prezizaane-type倍半萜(SPS)作为一类特殊的倍半萜,具有高度氧化的五环笼状结构和七个连续的手性中心,是从茵陈属植物中分离出来的,具有多种生物活性,包括神经毒性和神经营养作用等。本综述概述了 SPS 的化学成分和药理作用,并探讨了未来研究的潜在趋势和范围。
{"title":"Chemical composition and pharmacological activity of seco-prezizaane-type sesquiterpenes","authors":"Ye Jin ,&nbsp;Yanqing Xie ,&nbsp;Peng Zhang ,&nbsp;Afsar Khan ,&nbsp;Zhihong Zhou ,&nbsp;Lu Liu","doi":"10.1016/j.chmed.2023.06.003","DOIUrl":"10.1016/j.chmed.2023.06.003","url":null,"abstract":"<div><p>The seco-prezizaane-type sesquiterpenes (SPS), as a special class of sesquiterpenes with a highly oxidative five-ring cage structure and seven consecutive chiral centers, are isolated from the genus <em>Illicium</em>, which have a variety of biological activities, including neurotoxicity and neurotrophic effects, etc. This review summarizes the chemical constituents and pharmacological effects of SPS, and discusses the potential trend and scope of future research.</p></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1674638423001065/pdfft?md5=b3ce3d2391ed5c6b301c5620be1bb9fa&pid=1-s2.0-S1674638423001065-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139018931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Strategies on biosynthesis and production of bioactive compounds in medicinal plants 药用植物中生物活性物质的合成与生产策略
IF 3.8 4区 医学 Q2 Medicine Pub Date : 2024-01-01 DOI: 10.1016/j.chmed.2023.01.007
Miaoxian Guo , Haizhou Lv , Hongyu Chen , Shuting Dong , Jianhong Zhang , Wanjing Liu , Liu He , Yimian Ma , Hua Yu , Shilin Chen , Hongmei Luo

Medicinal plants are a valuable source of essential medicines and herbal products for healthcare and disease therapy. Compared with chemical synthesis and extraction, the biosynthesis of natural products is a very promising alternative for the successful conservation of medicinal plants, and its rapid development will greatly facilitate the conservation and sustainable utilization of medicinal plants. Here, we summarize the advances in strategies and methods concerning the biosynthesis and production of natural products of medicinal plants. The strategies and methods mainly include genetic engineering, plant cell culture engineering, metabolic engineering, and synthetic biology based on multiple “OMICS” technologies, with paradigms for the biosynthesis of terpenoids and alkaloids. We also highlight the biosynthetic approaches and discuss progress in the production of some valuable natural products, exemplifying compounds such as vindoline (alkaloid), artemisinin and paclitaxel (terpenoids), to illustrate the power of biotechnology in medicinal plants.

药用植物是医疗保健和疾病治疗所需的基本药物和草药产品的宝贵来源。与化学合成和提取相比,天然产物的生物合成是成功保护药用植物的一种非常有前景的替代方法,它的快速发展将极大地促进药用植物的保护和可持续利用。在此,我们总结了有关药用植物天然产物生物合成和生产的策略和方法的进展。这些策略和方法主要包括基因工程、植物细胞培养工程、代谢工程和基于多种 "OMICS "技术的合成生物学,以及萜类化合物和生物碱的生物合成范例。我们还重点介绍了生物合成方法,并讨论了一些有价值的天然产品的生产进展,例如吲哚啉(生物碱)、青蒿素和紫杉醇(萜类化合物)等化合物,以说明生物技术在药用植物中的力量。
{"title":"Strategies on biosynthesis and production of bioactive compounds in medicinal plants","authors":"Miaoxian Guo ,&nbsp;Haizhou Lv ,&nbsp;Hongyu Chen ,&nbsp;Shuting Dong ,&nbsp;Jianhong Zhang ,&nbsp;Wanjing Liu ,&nbsp;Liu He ,&nbsp;Yimian Ma ,&nbsp;Hua Yu ,&nbsp;Shilin Chen ,&nbsp;Hongmei Luo","doi":"10.1016/j.chmed.2023.01.007","DOIUrl":"10.1016/j.chmed.2023.01.007","url":null,"abstract":"<div><p>Medicinal plants are a valuable source of essential medicines and herbal products for healthcare and disease therapy. Compared with chemical synthesis and extraction, the biosynthesis of natural products is a very promising alternative for the successful conservation of medicinal plants, and its rapid development will greatly facilitate the conservation and sustainable utilization of medicinal plants. Here, we summarize the advances in strategies and methods concerning the biosynthesis and production of natural products of medicinal plants. The strategies and methods mainly include genetic engineering, plant cell culture engineering, metabolic engineering, and synthetic biology based on multiple “OMICS” technologies, with paradigms for the biosynthesis of terpenoids and alkaloids. We also highlight the biosynthetic approaches and discuss progress in the production of some valuable natural products, exemplifying compounds such as vindoline (alkaloid), artemisinin and paclitaxel (terpenoids), to illustrate the power of biotechnology in medicinal plants.</p></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1674638423000734/pdfft?md5=e7c0c5117f521c86ee9c1aa10033f232&pid=1-s2.0-S1674638423000734-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46917564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chuanxiong Rhizoma extracts prevent liver fibrosis via targeting CTCF-c-MYC-H19 pathway 川芎提取物通过靶向 CTCF-c-MYC-H19 通路预防肝纤维化
IF 3.8 4区 医学 Q2 Medicine Pub Date : 2024-01-01 DOI: 10.1016/j.chmed.2023.07.003
Yajing Li , Fanghong Li , Mingning Ding , Zhi Ma , Shuo Li , Jiaorong Qu , Xiaojiaoyang Li

Objective

Hepatic fibrosis has been widely considered as a conjoint consequence of almost all chronic liver diseases. Chuanxiong Rhizoma (Chuanxiong in Chinese, CX) is a traditional Chinese herbal product to prevent cerebrovascular, gynecologic and hepatic diseases. Our previous study found that CX extracts significantly reduced collagen contraction force of hepatic stellate cells (HSCs). Here, this study aimed to compare the protection of different CX extracts on bile duct ligation (BDL)-induced liver fibrosis and investigate plausible underlying mechanisms.

Methods

The active compounds of CX extracts were identified by high performance liquid chromatography (HPLC). Network pharmacology was used to determine potential targets of CX against hepatic fibrosis. Bile duct hyperplasia and liver fibrosis were evaluated by serologic testing and histopathological evaluation. The expression of targets of interest was determined by quantitative real-time PCR (qPCR) and Western blot.

Results

Different CX extracts were identified by tetramethylpyrazine, ferulic acid and senkyunolide A. Based on the network pharmacological analysis, 42 overlap targets were obtained via merging the candidates targets of CX and liver fibrosis. Different aqueous, alkaloid and phthalide extracts of CX (CXAE, CXAL and CXPHL) significantly inhibited diffuse severe bile duct hyperplasia and thus suppressed hepatic fibrosis by decreasing CCCTC binding factor (CTCF)-c-MYC-long non-coding RNA H19 (H19) pathway in the BDL-induced mouse model. Meanwhile, CX extracts, especially CXAL and CXPHL also suppressed CTCF-c-MYC-H19 pathway and inhibited ductular reaction in cholangiocytes stimulated with taurocholate acid (TCA), lithocholic acid (LCA) and transforming growth factor beta (TGF-β), as illustrated by decreased bile duct proliferation markers.

Conclusion

Our data supported that different CX extracts, especially CXAL and CXPHL significantly alleviated hepatic fibrosis and bile duct hyperplasia via inhibiting CTCF-c-MYC-H19 pathway, providing novel insights into the anti-fibrotic mechanism of CX.

目的肝纤维化被广泛认为是几乎所有慢性肝病的并发症。川芎是预防脑血管、妇科和肝脏疾病的传统中药。我们之前的研究发现,川芎提取物能显著降低肝星状细胞(HSCs)的胶原收缩力。本研究旨在比较不同的 CX 提取物对胆管结扎(BDL)诱导的肝纤维化的保护作用,并探讨其可能的内在机制。利用网络药理学确定了 CX 抗肝纤维化的潜在靶点。通过血清学检测和组织病理学评估来评价胆管增生和肝纤维化。结果通过四甲基吡嗪、阿魏酸和森久内酯 A 鉴别了不同的 CX 提取物。根据网络药理学分析,通过合并 CX 和肝纤维化的候选靶点,得到了 42 个重叠靶点。在 BDL 诱导的小鼠模型中,不同的 CX 水提取物、生物碱提取物和邻苯二甲酸酯提取物(CXAE、CXAL 和 CXPHL)能显著抑制弥漫性重度胆管增生,从而通过降低 CCCTC 结合因子(CTCF)-c-MYC-长非编码 RNA H19(H19)通路抑制肝纤维化。同时,CX 提取物,尤其是 CXAL 和 CXPHL 还能抑制 CTCF-c-MYC-H19 通路,并抑制胆管细胞在牛磺胆酸盐(TCA)、石胆酸盐(LCA)和转化生长因子 beta(TGF-β)刺激下的导管反应,胆管增殖标志物的减少也说明了这一点。结论我们的数据支持不同的 CX 提取物,尤其是 CXAL 和 CXPHL,通过抑制 CTCF-c-MYC-H19 通路显著缓解肝纤维化和胆管增生,为 CX 的抗纤维化机制提供了新的见解。
{"title":"Chuanxiong Rhizoma extracts prevent liver fibrosis via targeting CTCF-c-MYC-H19 pathway","authors":"Yajing Li ,&nbsp;Fanghong Li ,&nbsp;Mingning Ding ,&nbsp;Zhi Ma ,&nbsp;Shuo Li ,&nbsp;Jiaorong Qu ,&nbsp;Xiaojiaoyang Li","doi":"10.1016/j.chmed.2023.07.003","DOIUrl":"10.1016/j.chmed.2023.07.003","url":null,"abstract":"<div><h3>Objective</h3><p>Hepatic fibrosis has been widely considered as a conjoint consequence of almost all chronic liver diseases. <em>Chuanxiong Rhizoma</em> (Chuanxiong in Chinese, CX) is a traditional Chinese herbal product to prevent cerebrovascular, gynecologic and hepatic diseases. Our previous study found that CX extracts significantly reduced collagen contraction force of hepatic stellate cells (HSCs). Here, this study aimed to compare the protection of different CX extracts on bile duct ligation (BDL)-induced liver fibrosis and investigate plausible underlying mechanisms.</p></div><div><h3>Methods</h3><p>The active compounds of CX extracts were identified by high performance liquid chromatography (HPLC). Network pharmacology was used to determine potential targets of CX against hepatic fibrosis. Bile duct hyperplasia and liver fibrosis were evaluated by serologic testing and histopathological evaluation. The expression of targets of interest was determined by quantitative real-time PCR (qPCR) and Western blot.</p></div><div><h3>Results</h3><p>Different CX extracts were identified by tetramethylpyrazine, ferulic acid and senkyunolide A. Based on the network pharmacological analysis, 42 overlap targets were obtained via merging the candidates targets of CX and liver fibrosis. Different aqueous, alkaloid and phthalide extracts of CX (CX<sub>AE</sub>, CX<sub>AL</sub> and CX<sub>PHL</sub>) significantly inhibited diffuse severe bile duct hyperplasia and thus suppressed hepatic fibrosis by decreasing CCCTC binding factor (CTCF)-c-MYC-long non-coding RNA H19 (H19) pathway in the BDL-induced mouse model. Meanwhile, CX extracts, especially CX<sub>AL</sub> and CX<sub>PHL</sub> also suppressed CTCF-c-MYC-H19 pathway and inhibited ductular reaction in cholangiocytes stimulated with taurocholate acid (TCA), lithocholic acid (LCA) and transforming growth factor beta (TGF-<em>β</em>), as illustrated by decreased bile duct proliferation markers.</p></div><div><h3>Conclusion</h3><p>Our data supported that different CX extracts, especially CX<sub>AL</sub> and CX<sub>PHL</sub> significantly alleviated hepatic fibrosis and bile duct hyperplasia via inhibiting CTCF-c-MYC-H19 pathway, providing novel insights into the anti-fibrotic mechanism of CX.</p></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S167463842300103X/pdfft?md5=d8ba39991875e90c9cb536337c0c8aac&pid=1-s2.0-S167463842300103X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139291440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Consensus statement on research and application of Chinese herbal medicine derived extracellular vesicles-like particles (2023 edition) 中药提取细胞外囊泡样颗粒的研究与应用共识声明(2023年版)
IF 3.8 4区 医学 Q2 Medicine Pub Date : 2024-01-01 DOI: 10.1016/j.chmed.2023.11.002
Qing Zhao , Tong Wang , Hongbin Wang , Peng Cao , Chengyu Jiang , Hongzhi Qiao , Lihua Peng , Xingdong Lin , Yunyao Jiang , Honglei Jin , Huantian Zhang , Shengpeng Wang , Yang Wang , Ying Wang , Xi Chen , Junbing Fan , Bo Li , Geng Li , Bifeng Liu , Zhiyang Li , Kewei Zhao

To promote the development of extracellular vesicles of herbal medicine especially the establishment of standardization, led by the National Expert Committee on Research and Application of Chinese Herbal Vesicles, research experts in the field of herbal medicine and extracellular vesicles were invited nationwide with the support of the Expert Committee on Research and Application of Chinese Herbal Vesicles, Professional Committee on Extracellular Vesicle Research and Application, Chinese Society of Research Hospitals and the Guangdong Engineering Research Center of Chinese Herbal Vesicles. Based on the collation of relevant literature, we have adopted the Delphi method, the consensus meeting method combined with the nominal group method to form a discussion draft of “Consensus statement on research and application of Chinese herbal medicine derived extracellular vesicles-like particles (2023)”. The first draft was discussed in online and offline meetings on October 12, 14, November 2, 2022 and April and May 2023 on the current status of research, nomenclature, isolation methods, quality standards and research applications of extracellular vesicles of Chinese herbal medicines, and 13 consensus opinions were finally formed. At the Third Academic Conference on Research and Application of Chinese Herbal Vesicles, held on May 26, 2023, Kewei Zhao, convenor of the consensus, presented and read the consensus to the experts of the Expert Committee on Research and Application of Chinese Herbal Vesicles. The consensus highlights the characteristics and advantages of Chinese medicine, inherits the essence, and keeps the righteousness and innovation, aiming to provide a reference for colleagues engaged in research and application of Chinese herbal vesicles at home and abroad, decode the mystery behind Chinese herbal vesicles together, establish a safe, effective and controllable accurate Chinese herbal vesicle prevention and treatment system, and build a bridge for Chinese medicine to the world.

为促进中药胞外囊泡的发展,特别是标准化的建立,在全国中药囊泡研究与应用专家委员会的领导下,在中药囊泡研究与应用专家委员会、胞外囊泡研究与应用专业委员会、中国研究型医院学会、广东省中药囊泡工程技术研究中心的支持下,面向全国邀请中药及胞外囊泡领域的研究专家。在整理相关文献的基础上,我们采用德尔菲法、共识会议法结合名义小组法,形成了《中药衍生胞外囊泡类颗粒研究与应用共识声明(2023)》讨论稿。初稿分别于2022年10月12日、14日、11月2日和2023年4月、5月,就中药胞外囊泡的研究现状、命名方法、分离方法、质量标准、研究应用等方面进行了线上线下会议讨论,最终形成了13条共识意见。在2023年5月26日召开的第三届中药囊泡研究与应用学术会议上,共识召集人赵克伟向中药囊泡研究与应用专家委员会专家介绍并宣读了共识。共识》突出中医药特色和优势,继承精华,守正创新,旨在为国内外从事中药泡腾片研究与应用的同仁提供参考,共同破解中药泡腾片背后的奥秘,建立安全、有效、可控的精准中药泡腾片防治体系,搭建中医药走向世界的桥梁。
{"title":"Consensus statement on research and application of Chinese herbal medicine derived extracellular vesicles-like particles (2023 edition)","authors":"Qing Zhao ,&nbsp;Tong Wang ,&nbsp;Hongbin Wang ,&nbsp;Peng Cao ,&nbsp;Chengyu Jiang ,&nbsp;Hongzhi Qiao ,&nbsp;Lihua Peng ,&nbsp;Xingdong Lin ,&nbsp;Yunyao Jiang ,&nbsp;Honglei Jin ,&nbsp;Huantian Zhang ,&nbsp;Shengpeng Wang ,&nbsp;Yang Wang ,&nbsp;Ying Wang ,&nbsp;Xi Chen ,&nbsp;Junbing Fan ,&nbsp;Bo Li ,&nbsp;Geng Li ,&nbsp;Bifeng Liu ,&nbsp;Zhiyang Li ,&nbsp;Kewei Zhao","doi":"10.1016/j.chmed.2023.11.002","DOIUrl":"10.1016/j.chmed.2023.11.002","url":null,"abstract":"<div><p>To promote the development of extracellular vesicles of herbal medicine especially the establishment of standardization, led by the National Expert Committee on Research and Application of Chinese Herbal Vesicles, research experts in the field of herbal medicine and extracellular vesicles were invited nationwide with the support of the Expert Committee on Research and Application of Chinese Herbal Vesicles, Professional Committee on Extracellular Vesicle Research and Application, Chinese Society of Research Hospitals and the Guangdong Engineering Research Center of Chinese Herbal Vesicles. Based on the collation of relevant literature, we have adopted the Delphi method, the consensus meeting method combined with the nominal group method to form a discussion draft of “Consensus statement on research and application of Chinese herbal medicine derived extracellular vesicles-like particles (2023)”. The first draft was discussed in online and offline meetings on October 12, 14, November 2, 2022 and April and May 2023 on the current status of research, nomenclature, isolation methods, quality standards and research applications of extracellular vesicles of Chinese herbal medicines, and 13 consensus opinions were finally formed. At the Third Academic Conference on Research and Application of Chinese Herbal Vesicles, held on May 26, 2023, Kewei Zhao, convenor of the consensus, presented and read the consensus to the experts of the Expert Committee on Research and Application of Chinese Herbal Vesicles. The consensus highlights the characteristics and advantages of Chinese medicine, inherits the essence, and keeps the righteousness and innovation, aiming to provide a reference for colleagues engaged in research and application of Chinese herbal vesicles at home and abroad, decode the mystery behind Chinese herbal vesicles together, establish a safe, effective and controllable accurate Chinese herbal vesicle prevention and treatment system, and build a bridge for Chinese medicine to the world.</p></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1674638423001107/pdfft?md5=bf5fe2945fabc69995f27c440126c3db&pid=1-s2.0-S1674638423001107-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138991419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
DNA metabarcoding analysis of fungal community on surface of four root herbs 四种根草本植物表面真菌群落的DNA代谢编码分析
IF 3.8 4区 医学 Q2 Medicine Pub Date : 2024-01-01 DOI: 10.1016/j.chmed.2023.01.003
Yujie Dao, Jingsheng Yu, Meihua Yang, Jianping Han, Chune Fan, Xiaohui Pang

Objective

Angelicae Sinensis Radix (ASR, Danggui in Chinese), Cistanches Herba (CH, Roucongrong in Chinese), Ginseng Radix et Rhizoma (PG, Renshen in Chinese), and Panacis Quinquefolii Radix (PQ, Xiyangshen in Chinese), widely used as medicine and dietary supplement around the world, are susceptible to fungal and mycotoxin contamination. In this study, we aim to analyze their fungal community by DNA metabarcoding.

Methods

A total of 12 root samples were collected from three main production areas in China. The samples were divided into four groups based on herb species, including ASR, CH, PG, and PQ groups. The fungal community on the surface of four root groups was investigated through DNA metabarcoding via targeting the internal transcribed spacer 2 region (ITS2).

Results

All the 12 samples were detected with fungal contamination. Rhizopus (13.04%−74.03%), Aspergillus (1.76%−23.92%), and Fusarium (0.26%−15.27%) were the predominant genera. Ten important fungi were identified at the species level, including two potential toxigenic fungi (Penicillium citrinum and P. oxalicum) and eight human pathogenic fungi (Alternaria infectoria, Candida sake, Hyphopichia burtonii, Malassezia globosa, M. restricta, Rhizopus arrhizus, Rhodotorula mucilaginosa, and Ochroconis tshawytschae). Fungal community in ASR and CH groups was significantly different from other groups, while fungal community in PG and PQ groups was relatively similar.

Conclusion

DNA metabarcoding revealed the fungal community in four important root herbs. This study provided an important reference for preventing root herbs against fungal and mycotoxin contamination.

目的全世界广泛用作药物和膳食补充剂的当归、肉苁蓉、人参和板蓝根容易受到真菌和霉菌毒素的污染。本研究旨在通过 DNA 代谢编码分析其真菌群落。根据药材种类将样本分为四组,包括 ASR 组、CH 组、PG 组和 PQ 组。结果 所有 12 份样品均检出真菌污染。根瘤菌(13.04%-74.03%)、曲霉(1.76%-23.92%)和镰刀菌(0.26%-15.27%)是主要的真菌属。在物种水平上确定了 10 种重要真菌,包括 2 种潜在的致毒真菌(柠檬青霉和草青霉)和 8 种人类致病真菌(Alternaria infectoria、Candida sake、Hyphopichia burtonii、Malassezia globosa、M. restricta、Rhizopus arrhizus、Rhodotorula mucilaginosa 和 Ochroconis tshawytschae)。ASR 组和 CH 组的真菌群落与其他组有显著差异,而 PG 组和 PQ 组的真菌群落则相对相似。这项研究为防止根茎类药材受到真菌和霉菌毒素污染提供了重要参考。
{"title":"DNA metabarcoding analysis of fungal community on surface of four root herbs","authors":"Yujie Dao,&nbsp;Jingsheng Yu,&nbsp;Meihua Yang,&nbsp;Jianping Han,&nbsp;Chune Fan,&nbsp;Xiaohui Pang","doi":"10.1016/j.chmed.2023.01.003","DOIUrl":"10.1016/j.chmed.2023.01.003","url":null,"abstract":"<div><h3>Objective</h3><p><em>Angelicae Sinensis Radix</em> (ASR, Danggui in Chinese), <em>Cistanches Herba</em> (CH, Roucongrong in Chinese), <em>Ginseng Radix</em> et <em>Rhizoma</em> (PG, Renshen in Chinese), and <em>Panacis Quinquefolii Radix</em> (PQ, Xiyangshen in Chinese), widely used as medicine and dietary supplement around the world, are susceptible to fungal and mycotoxin contamination. In this study, we aim to analyze their fungal community by DNA metabarcoding.</p></div><div><h3>Methods</h3><p>A total of 12 root samples were collected from three main production areas in China. The samples were divided into four groups based on herb species, including ASR, CH, PG, and PQ groups. The fungal community on the surface of four root groups was investigated through DNA metabarcoding via targeting the internal transcribed spacer 2 region (ITS2).</p></div><div><h3>Results</h3><p>All the 12 samples were detected with fungal contamination. <em>Rhizopus</em> (13.04%−74.03%), <em>Aspergillus</em> (1.76%−23.92%), and <em>Fusarium</em> (0.26%−15.27%) were the predominant genera. Ten important fungi were identified at the species level, including two potential toxigenic fungi (<em>Penicillium citrinum</em> and <em>P</em>. <em>oxalicum</em>) and eight human pathogenic fungi (<em>Alternaria infectoria</em>, <em>Candida sake</em>, <em>Hyphopichia burtonii</em>, <em>Malassezia globosa</em>, <em>M</em>. <em>restricta</em>, <em>Rhizopus arrhizus</em>, <em>Rhodotorula mucilaginosa</em>, and <em>Ochroconis tshawytschae</em>). Fungal community in ASR and CH groups was significantly different from other groups, while fungal community in PG and PQ groups was relatively similar.</p></div><div><h3>Conclusion</h3><p>DNA metabarcoding revealed the fungal community in four important root herbs. This study provided an important reference for preventing root herbs against fungal and mycotoxin contamination.</p></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1674638423000461/pdfft?md5=a057dc5cad3ba0b1c38dea69ba691bd5&pid=1-s2.0-S1674638423000461-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47427595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gain deeper insights into traditional Chinese medicines using multidimensional chromatography combined with chemometric approaches 利用多维色谱结合化学计量学方法深入了解传统中药
IF 3.8 4区 医学 Q2 Medicine Pub Date : 2024-01-01 DOI: 10.1016/j.chmed.2023.07.001
Xinyue Yang , Pingping Zeng , Jin Wen , Chuanlin Wang , Liangyuan Yao , Min He

Traditional Chinese medicines (TCMs) possess a rich historical background, unique theoretical framework, remarkable therapeutic efficacy, and abundant resources. However, the modernization and internationalization of TCMs have faced significant obstacles due to their diverse ingredients and unknown mechanisms. To gain deeper insights into the phytochemicals and ensure the quality control of TCMs, there is an urgent need to enhance analytical techniques. Currently, two-dimensional (2D) chromatography, which incorporates two independent separation mechanisms, demonstrates superior separation capabilities compared to the traditional one-dimensional (1D) separation system when analyzing TCMs samples. Over the past decade, new techniques have been continuously developed to gain actionable insights from complex samples. This review presents the recent advancements in the application of multidimensional chromatography for the quality evaluation of TCMs, encompassing 2D-gas chromatography (GC), 2D-liquid chromatography (LC), as well as emerging three-dimensional (3D)-GC, 3D-LC, and their associated data-processing approaches. These studies highlight the promising potential of multidimensional chromatographic separation for future phytochemical analysis. Nevertheless, the increased separation capability has resulted in higher-order data sets and greater demands for data-processing tools. Considering that multidimensional chromatography is still a relatively nascent research field, further hardware enhancements and the implementation of chemometric methods are necessary to foster its robust development.

中药具有丰富的历史背景、独特的理论框架、显著的疗效和丰富的资源。然而,由于中药成分多样、机理不明,中药的现代化和国际化面临着巨大障碍。为了深入了解植物化学成分,确保中药的质量控制,迫切需要提高分析技术。目前,与传统的一维(1D)分离系统相比,包含两种独立分离机制的二维(2D)色谱法在分析中药样品时显示出更优越的分离能力。在过去十年中,人们不断开发新技术,以便从复杂样品中获得可行的见解。本综述介绍了应用多维色谱进行中药质量评估的最新进展,包括二维气相色谱 (GC)、二维液相色谱 (LC),以及新兴的三维 (3D)-GC 和 3D-LC 及其相关数据处理方法。这些研究凸显了多维色谱分离在未来植物化学分析中的巨大潜力。然而,分离能力的提高带来了更高阶的数据集,也对数据处理工具提出了更高的要求。考虑到多维色谱法仍是一个相对新兴的研究领域,有必要进一步改进硬件并实施化学计量学方法,以促进其稳健发展。
{"title":"Gain deeper insights into traditional Chinese medicines using multidimensional chromatography combined with chemometric approaches","authors":"Xinyue Yang ,&nbsp;Pingping Zeng ,&nbsp;Jin Wen ,&nbsp;Chuanlin Wang ,&nbsp;Liangyuan Yao ,&nbsp;Min He","doi":"10.1016/j.chmed.2023.07.001","DOIUrl":"10.1016/j.chmed.2023.07.001","url":null,"abstract":"<div><p>Traditional Chinese medicines (TCMs) possess a rich historical background, unique theoretical framework, remarkable therapeutic efficacy, and abundant resources. However, the modernization and internationalization of TCMs have faced significant obstacles due to their diverse ingredients and unknown mechanisms. To gain deeper insights into the phytochemicals and ensure the quality control of TCMs, there is an urgent need to enhance analytical techniques. Currently, two-dimensional (2D) chromatography, which incorporates two independent separation mechanisms, demonstrates superior separation capabilities compared to the traditional one-dimensional (1D) separation system when analyzing TCMs samples. Over the past decade, new techniques have been continuously developed to gain actionable insights from complex samples. This review presents the recent advancements in the application of multidimensional chromatography for the quality evaluation of TCMs, encompassing 2D-gas chromatography (GC), 2D-liquid chromatography (LC), as well as emerging three-dimensional (3D)-GC, 3D-LC, and their associated data-processing approaches. These studies highlight the promising potential of multidimensional chromatographic separation for future phytochemical analysis. Nevertheless, the increased separation capability has resulted in higher-order data sets and greater demands for data-processing tools. Considering that multidimensional chromatography is still a relatively nascent research field, further hardware enhancements and the implementation of chemometric methods are necessary to foster its robust development.</p></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1674638423001004/pdfft?md5=8922549bf8ef791e11211a87f5de8063&pid=1-s2.0-S1674638423001004-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135764295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anemoside B4 inhibits SARS-CoV-2 replication in vitro and in vivo 青蒿甙 B4 可抑制 SARS-CoV-2 在体外和体内的复制
IF 3.8 4区 医学 Q2 Medicine Pub Date : 2024-01-01 DOI: 10.1016/j.chmed.2023.09.005
Mingyue Xiao , Ronghua Luo , Qinghua Liang , Honglv Jiang , Yanli Liu , Guoqiang Xu , Hongwei Gao , Yongtang Zheng , Qiongming Xu , Shilin Yang

Objective

Anemoside B4 (AB4), the most abundant triterpenoidal saponin isolated from Pulsatilla chinensis, inhibited influenza virus FM1 or Klebsiella pneumoniae-induced pneumonia. However, the anti-SARS-CoV-2 effect of AB4 has not been unraveled. Therefore, this study aimed to determine the antiviral activity and potential mechanism of AB4 in inhibiting human coronavirus SARS-CoV-2 in vivo and in vitro.

Methods

The cytotoxicity of AB4 was evaluated using the Cell Counting Kit-8 (CCK8) assay. SARS-CoV-2 infected HEK293T, HPAEpiC, and Vero E6 cells were used for in vitro assays. The antiviral effect of AB4 in vivo was evaluated by SARS-CoV-2-infected hACE2-IRES-luc transgenic mouse model. Furthermore, label-free quantitative proteomics and bioinformatic analysis were performed to explore the potential antiviral mechanism of action of AB4. Type I IFN signaling-associated proteins were assessed using Western blotting or immumohistochemical staining.

Results

The data showed that AB4 reduced the propagation of SARS-CoV-2 along with the decreased Nucleocapsid protein (N), Spike protein (S), and 3C-like protease (3CLpro) in HEK293T cells. In vivo antiviral activity data revealed that AB4 inhibited viral replication and relieved pneumonia in a SARS-CoV-2 infected mouse model. We further disclosed that the antiviral activity of AB4 was associated with the enhanced interferon (IFN)-β response via the activation of retinoic acid-inducible gene I (RIG-1) like receptor (RLP) pathways. Additionally, label-free quantitative proteomic analyses discovered that 17 proteins were significantly altered by AB4 in the SARS-CoV-2 coronavirus infections cells. These proteins mainly clustered in RNA metabolism.

Conclusion

Our results indicated that AB4 inhibited SARS-CoV-2 replication through the RLR pathways and moderated the RNA metabolism, suggesting that it would be a potential lead compound for the development of anti-SARS-CoV-2 drugs.

目的从白头翁中分离出的最丰富的三萜皂苷 B4(AB4)可抑制流感病毒 FM1 或肺炎克雷伯氏菌诱发的肺炎。然而,AB4 的抗 SARS-CoV-2 作用尚未被揭示。因此,本研究旨在确定 AB4 在体内和体外抑制人类冠状病毒 SARS-CoV-2 的抗病毒活性和潜在机制。体外试验使用了感染 SARS-CoV-2 的 HEK293T、HPAEpiC 和 Vero E6 细胞。通过SARS-CoV-2感染hACE2-IRES-luc转基因小鼠模型评估了AB4在体内的抗病毒作用。此外,还进行了无标记定量蛋白质组学和生物信息学分析,以探索 AB4 潜在的抗病毒作用机制。结果表明,AB4能降低SARS-CoV-2在HEK293T细胞中的传播,同时减少核头壳蛋白(N)、尖峰蛋白(S)和3C样蛋白酶(3CLpro)。体内抗病毒活性数据显示,AB4 可抑制病毒复制,并缓解 SARS-CoV-2 感染小鼠模型的肺炎。我们进一步发现,AB4 的抗病毒活性与通过激活类视黄酸诱导基因 I(RIG-1)受体(RLP)途径增强干扰素(IFN)-β 反应有关。此外,无标记定量蛋白质组分析发现,AB4 在 SARS-CoV-2 冠状病毒感染细胞中显著改变了 17 种蛋白质。结论我们的研究结果表明,AB4 通过 RLR 途径抑制了 SARS-CoV-2 的复制,并缓和了 RNA 代谢,这表明它将成为开发抗 SARS-CoV-2 药物的潜在先导化合物。
{"title":"Anemoside B4 inhibits SARS-CoV-2 replication in vitro and in vivo","authors":"Mingyue Xiao ,&nbsp;Ronghua Luo ,&nbsp;Qinghua Liang ,&nbsp;Honglv Jiang ,&nbsp;Yanli Liu ,&nbsp;Guoqiang Xu ,&nbsp;Hongwei Gao ,&nbsp;Yongtang Zheng ,&nbsp;Qiongming Xu ,&nbsp;Shilin Yang","doi":"10.1016/j.chmed.2023.09.005","DOIUrl":"10.1016/j.chmed.2023.09.005","url":null,"abstract":"<div><h3>Objective</h3><p>Anemoside B4 (AB4), the most abundant triterpenoidal saponin isolated from <em>Pulsatilla chinensis</em>, inhibited influenza virus FM1 or <em>Klebsiella pneumoniae</em>-induced pneumonia. However, the anti-SARS-CoV-2 effect of AB4 has not been unraveled. Therefore, this study aimed to determine the antiviral activity and potential mechanism of AB4 in inhibiting human coronavirus SARS-CoV-2 <em>in vivo</em> and <em>in vitro</em>.</p></div><div><h3>Methods</h3><p>The cytotoxicity of AB4 was evaluated using the Cell Counting Kit-8 (CCK8) assay. SARS-CoV-2 infected HEK293T, HPAEpiC, and Vero E6 cells were used for <em>in vitro</em> assays. The antiviral effect of AB4 <em>in vivo</em> was evaluated by SARS-CoV-2-infected hACE2-IRES-luc transgenic mouse model. Furthermore, label-free quantitative proteomics and bioinformatic analysis were performed to explore the potential antiviral mechanism of action of AB4. Type I IFN signaling-associated proteins were assessed using Western blotting or immumohistochemical staining.</p></div><div><h3>Results</h3><p>The data showed that AB4 reduced the propagation of SARS-CoV-2 along with the decreased Nucleocapsid protein (N), Spike protein (S), and 3C-like protease (3CLpro) in HEK293T cells. <em>In vivo</em> antiviral activity data revealed that AB4 inhibited viral replication and relieved pneumonia in a SARS-CoV-2 infected mouse model. We further disclosed that the antiviral activity of AB4 was associated with the enhanced interferon (IFN)-β response <em>via</em> the activation of retinoic acid-inducible gene I (RIG-1) like receptor (RLP) pathways. Additionally, label-free quantitative proteomic analyses discovered that 17 proteins were significantly altered by AB4 in the SARS-CoV-2 coronavirus infections cells. These proteins mainly clustered in RNA metabolism.</p></div><div><h3>Conclusion</h3><p>Our results indicated that AB4 inhibited SARS-CoV-2 replication through the RLR pathways and moderated the RNA metabolism, suggesting that it would be a potential lead compound for the development of anti-SARS-CoV-2 drugs.</p></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1674638423001089/pdfft?md5=a228a84cdfef70160b6bb41e1ac28864&pid=1-s2.0-S1674638423001089-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138993115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Chinese Herbal Medicines
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1